Neinor Homes accelerates FY26 shareholder distributions with a €92mn (€0.93/sh) supported by strong deliveries outlookThis payment represents the first instalment of FY26 shareholder distribution target of €250mn (DPS €2.53/sh), equivalent to c.13% annual yieldThe last trading day to be entitled to the first annual distribution will be February 9Under its 2023–2027 Strategic Plan, Neinor has already distributed €451mn to shareholders, representing c.€5.0/sh and over 50% of the €850mn distribution targetMadrid, 2 February 2026– Neinor Homes (“Neinor”) will distribute €92mn to its shareholders on February 12, equivalent to a yield of approximately 5%. This payment represents the first instalment of the €250mn dividend corresponding to FY26. The distribution amounts to a gross payment of €0.9327/sh, equivalent to a net payment...

NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) — Adamas Trust, Inc. (Nasdaq: ADAM) (“Adamas” or the “Company”) today announced the following tax treatment of common and preferred stock dividends paid in 2025. This information is provided to assist stockholders with tax reporting requirements related to dividend distributions of taxable income by the Company. Stockholders should review the 2025 tax statements received from their brokerage firms or other institutions to ensure that the statements agree with the information provided below. Also, as each stockholder’s tax situation may be different, stockholders are encouraged to consult with their own professional tax advisor with respect to their specific tax treatment of the Company’s dividend distributions. Adamas is required to report the portion of its 2025 dividends that...

UNIONDALE, N.Y., Jan. 30, 2026 (GLOBE NEWSWIRE) — Arbor Realty Trust, Inc. (NYSE: ABR), today announced the tax treatment of its 2025 dividend distributions for common and preferred shares of beneficial interest. For tax reporting purposes, 100% of the distributions paid on our common stock during 2025 will be classified as dividend income. The 2025 taxable distributions with respect to our common stock traded under ticker symbol ABR are summarized as follows:                     Common Shares (CUSIP #038923108)Record Date   Payment Date   Total Distribution Per Share   Non-Qualified Dividend (1)   Qualified Dividend   Capital Gain Distribution3/7/2025   3/21/2025   $0.43   $0.19   $0.24   $0.005/16/2025   5/30/2025   0.30   0.13   0.17   0.008/15/2025   8/29/2025   0.30   0.13   0.17   0.0011/14/2025   11/26/2025   0.30   0.13   0.17   0.00        $1.33   $0.58   $0.75   $0.00                     The...

Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to ShareholdersTevogen Board to Evaluate Potential One-Time Special Cash Dividend to ShareholdersWARREN, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that its Board of Directors has expressed its intention to evaluate the potential declaration of a one-time special cash dividend to shareholders, contingent upon the achievement of specified financial milestones to be determined at a future date, which could include revenue and earnings targets. Any consideration of a special dividend would be subject to the Company’s future financial performance, capital requirements, compliance with applicable solvency laws, including under the Delaware General Corporation Law, and final approval...

ANCHORAGE, Alaska, Jan. 30, 2026 (GLOBE NEWSWIRE) — At the Board of Directors Meeting held January 29, 2026, a cash dividend of $4.00 per share was declared, payable on March 16, 2026, to shareholders of record as of February 27, 2026. CONTACT: Denise Brown RobinsonSecretary to the Board of Directors907-777-3409

MONTREAL, Jan. 30, 2026 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) announced today that its Board of Directors has approved a 3% increase in the 2026 dividend on the Company’s outstanding common shares as well as the repurchase of its shares under a new normal course issuer bid (Bid). “These actions reflect CN’s strong cash flow and our disciplined approach to managing capital. We are investing in the business, returning capital to shareholders and maintaining a strong balance sheet to support long-term performance.”   –   Ghislain Houle, Executive Vice-President and Chief Financial Officer, CN The Bid permits CN to purchase, for cancellation, over a 12-month period up to 24 million common shares, representing 3.9% of the 613,523,348 common shares issued and outstanding of the Company on January 22, 2026. On that...

BROOKFIELD, News, Jan. 30, 2026 (GLOBE NEWSWIRE) — Brookfield Business Partners (NYSE: BBU, BBUC; TSX: BBU.UN, BBUC) announced today financial results for the year ended December 31, 2025. “We had a great year, generating over $2 billion from our capital recycling initiatives, investing $700 million in four growth acquisitions and repurchasing $235 million of our units and shares at a significant discount to intrinsic value,” said Anuj Ranjan, CEO of Brookfield Business Partners. “We are also nearing the completion of our corporate reorganization which should enhance global demand for our shares as we continue to progress our value creation and capital recycling plans to compound long-term growth for our investors.”  Three Months EndedDecember 31,   Year EndedDecember 31,US$ millions (except per unit amounts), unaudited   2025     2024       2025     2024  Net...

MISSISSAUGA, Ontario, Jan. 29, 2026 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.055 per common share, payable in Canadian Dollars on March 13, 2026, to shareholders of record at the close of business on February 27, 2026. This first quarter 2026 dividend represents a 10% increase from the fourth quarter 2025 dividend of $0.05 per common share. This dividend qualifies as an ‘eligible dividend’ for Canadian income tax purposes. The declaration, timing, amount and payment of future dividends remain at the discretion of the Board of Directors. About BioSyent Inc. Listed on the TSX Venture Exchange under the trading symbol “RX”, BioSyent is a profitable growth-oriented specialty pharmaceutical company...

VERO BEACH, Florida, Jan. 29, 2026 (GLOBE NEWSWIRE) — ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR-PRC) (“ARMOUR” or the “Company”) today announced the February 2026 cash dividend for the Company’s Common Stock. February 2026 Common Stock Dividend InformationMonth   Dividend   Holder of Record Date   Payment DateFebruary 2026   $0.24   February 17, 2026   February 27, 2026             Certain Tax Matters ARMOUR has elected to be taxed as a real estate investment trust (“REIT”) for U.S. Federal income tax purposes. In order to maintain this tax status, ARMOUR is required to timely distribute substantially all of its ordinary REIT taxable income. Dividends paid in excess of current tax earnings and profits for the year will generally not be taxable to common stockholders. Actual dividends are determined at...

TORONTO, Jan. 29, 2026 (GLOBE NEWSWIRE) — Ninepoint Partners LP (“Ninepoint Partners”) today announced the Final January 2026 cash distribution for the ETF Series of Ninepoint Cash Management Fund (the “Fund”). The record date for the cash distribution is January 30, 2026, payable on February 6, 2026. The actual taxable amounts of distributions for 2026, including the tax characteristics of the distributions, will be reported to CDS Clearing and Depository Services Inc. in early 2027. Securityholders can contact their brokerage firm for this information. The per-unit final January 2026 distribution is detailed below:Ninepoint ETF Series Ticker  Cash Distribution per unit  Notional Distribution per unit CUSIPNinepoint Cash Management Fund NSAV  $0.094220  $0.000000 65443X105About Ninepoint Partners Based in Toronto, Ninepoint...